OralAllergic conditionsAdult: As acetate, with chlorphenamine maleate: 1 mg tid, may increase up to 6 mg in 24 hr. Child: As acetate, with chlorphenamine maleate: 6-14 yr: 0.5 mg 3 to 4 times a day; max: 4 mg/day.
OralAnti-inflammatoryAdult: 2-24 mg/day
|
Tuberculosis, fungal infection, herpes, bone disease, thyroid disease, colitis, peptic ulcer, diabetes, myasthenia gravis, liver or kidney disease, diverticulitis, glaucoma, heart disease. Pregnancy.
|
Elderly, children, lactation. Avoid abrupt discontinuation, immunisation. Monitor growth in children.
|
Acne, poor wound healing, indigestion, nausea, vomiting, thirst, constipation, gaseousness, unpleasant taste, diarrhoea, headache, cough, dizziness, hoarseness, appetite gain or loss. Prolonged use: growth retardation in children, glaucoma, cataracts, diabetes, fragile bones, thin skin, functional dependence. Potentially Fatal: Anaphylaxis.
|
Headache, convulsions, heart failure.
|
Decreased effects with anticonvulsants, antihistamine, barbiturates, chloral hydrate, ephedrine, rifampin. Increased effects with NSAID, contraceptives, indomethacin, tobacco. Decreases effects of anticoagulants, antidiabetics, cholinergics, insulin, isoniazid, salicylates, potassium. Increases effects of theophylline. Increased risk of hypokalemia with amphotericin, chlorthalidone, thiazide diuretics, furosemide, digitalis preparations (possible digitalis toxicity). Increased risk of stomach ulcers with alcohol.
|
Description: Mechanism of Action: Paramethasone is a corticosteroid, used systemically for its glucocorticoid activity. 2 mg paramethasone is equivalent in anti-inflammatory activity to 5 mg prednisolone.
|
|